IFNAR1 and pneumonia: Conversely, and consistent with the lack of pneumonia in patients with MIS-C, a lung epithelial cell line and fibroblasts defective for this pathway restrict SARS-CoV-2 normally, unlike IFNAR1-deficient cells from patients prone to hypoxemic pneumonia without MIS-C.